Fundraising Fox

Intelligent BIO Solutions

NASDAQ: INBS

New York, US · Delaware corporation

ibs.inc ↗

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company that makes non-invasive drug testing products, including a fingerprint sweat analysis screening system and the SmarTest wearable sweat patch, to detect recent and longer-term drug use. Its products serve justice, rehabilitation, and workplace drug-screening markets and are sold across 35 countries while pursuing FDA clearance for U.S. entry.

HardwareHealthtechMedical Devices

Founders & leadership

SS
Spiro SakirisChief Financial Officer
HS
Harry SimeonidisChief Executive Officer
LF
Lawrence FisherNamed on SEC filing
GM
George MargelisNamed on SEC filing
CT
Christopher TowersNamed on SEC filing

Board

JI
Jason IsenbergBoard director
SB
Steven BoyagesBoard director
JH
Jonathan HurdBoard director
NF
Nicola FraserBoard director

Reported raises · per SEC filings

Form D private placements

$23.9M disclosed across 3 of 4 rounds · 2022–2025

▶$10MraisedJan 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason IsenbergDirector
  • Spiro SakirisExecutive Officer
  • Steven BoyagesDirector
  • Jonathan HurdDirector
  • Harry SimeonidisExecutive Officer
  • Nicola FraserDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$900K
Placement agents
Ladenburg Thalmann & Co. Inc.
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2025 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven BoyagesDirector
  • Jonathan HurdDirector
  • Spiro SakirisExecutive Officer
  • Harry SimeonidisExecutive Officer
  • Jason IsenbergDirector
  • Nicola FraserDirector
Offering amount
$3.8M
Amount sold
$3.8M
Sales commissions
$345.5K
Placement agents
Ladenburg Thalmann & Co. Inc.
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.1MraisedMar 2024 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven BoyagesDirector
  • Jason IsenbergDirector
  • Harry SimeonidisExecutive Officer
  • Christopher TowersDirector
  • Spiro SakirisExecutive Officer
  • Lawrence FisherDirector
  • Jonathan HurdDirector
Offering amount
$10.1M
Amount sold
$10.1M
Minimum investment
$10K
Sales commissions
$910.5K
Placement agents
Ladenburg Thalmann & Co. Inc.
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedOct 2022 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence FisherDirector
  • George MargelisDirector
  • Jonathan HurdDirector
  • Steven BoyagesExecutive Officer, Director
  • Spiro SakirisExecutive Officer
  • Harry SimeonidisExecutive Officer
  • Christopher TowersDirector
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Labcorp164 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.

Companies competing with Intelligent BIO Solutions for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Intelligent BIO Solutions do?
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company that makes non-invasive drug testing products, including a fingerprint sweat analysis screening system and the SmarTest wearable sweat patch, to detect recent and longer-term drug use. Its products serve justice, rehabilitation, and workplace drug-screening markets and are sold across 35 countries while pursuing FDA clearance for U.S. entry.
How much funding has Intelligent BIO Solutions raised?
Intelligent BIO Solutions has disclosed $23.9M raised across 3 of its 4 known rounds.
Where is Intelligent BIO Solutions headquartered?
Intelligent BIO Solutions is headquartered in New York, US.